Rossella Elisei
罗塞拉·埃利赛
MD, PhD
Professor of Endocrinology and Head, Endocrine Unit内分泌学教授兼内分泌科主任
👥Biography 个人简介
International leader in medullary thyroid cancer and RET oncology. Has made seminal contributions to understanding germline and somatic RET mutations in hereditary and sporadic medullary thyroid cancer and led major clinical trials of RET-targeted therapies including vandetanib and cabozantinib.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Medullary Thyroid Cancer RET Mutations
Characterized the spectrum of germline and somatic RET mutations in familial and sporadic medullary thyroid cancer and co-led pivotal trials of RET-targeted TKIs, establishing molecular diagnosis and targeted therapy as cornerstones of MTC management.
Representative Works 代表性著作
Cabozantinib in progressive medullary thyroid cancer
Journal of Clinical Oncology (2013)
EXAM trial demonstrating cabozantinib's progression-free survival benefit in advanced medullary thyroid cancer, leading to FDA approval.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 罗塞拉·埃利赛 的研究动态
Follow Rossella Elisei's research updates
留下邮箱，当我们发布与 Rossella Elisei（University of Pisa）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment